Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population

Citation
S. Sihvo et al., Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population, EUR J CL PH, 56(6-7), 2000, pp. 495-499
Citations number
18
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
ISSN journal
00316970 → ACNP
Volume
56
Issue
6-7
Year of publication
2000
Pages
495 - 499
Database
ISI
SICI code
0031-6970(200009)56:6-7<495:FODODU>2.0.ZU;2-A
Abstract
Objective: To explore the frequency of continuous use of over-the-counter ( OTC) drugs among the Finnish adult population and the potential for harmful interactions between OTC drugs and prescribed (Rx) drugs. Methods: Data were extracted from a 1995-1996 population-based interview su rvey on health care (n = 10,477, response rate 86%). The drug interaction c lassification system from the Swedish Drug Compendium FASS 1997 was used to identify OTC drugs likely to have clinically significant interactions with prescription drugs. Logistic regression was used to study factors related to continuous use and risks for interactions. Results. Seventeen percent of the population had used OTC drugs and 15% had used OTC vitamins during the 2 days prior to the interview. Daily use of O TC drugs and of vitamins was reported by 7% and 9%, respectively. Continuou s use of OTC drugs was related to older age, female gender, higher educatio n, poor health status, long-term morbidity, psychosomatic symptoms (fatigue ) and use of prescription drugs, but not to poor lifestyle. Four percent of the OTC drug users had taken drug combinations with potential for clinical ly significant interactions. Interactions were most common for ketoprofen ( 15% of ketoprofen users), ibuprofen (10%), and acetylsalicylic acid (ASA) ( 6%). The number of prescription drugs, long-term illness and lower educatio n best explained the risk for interactions. Conclusion: Continuous use and potentially harmful Rx/OTC drug interactions occur among OTC drug, users. Further studies should be done to investigate whether potential combinations will actually lead to clinical problems. Th e possible interactions of non-steroidal anti-inflammatory drugs (NSAIDs) a nd analgesics with prescription drugs should especially be taken into accou nt in drug information.